UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16
OR 15d-16
UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the month of
August 2024
Commission File Number 001-41749
PIXIE DUST TECHNOLOGIES, INC.
(Translation of registrant’s
name into English)
Pixie Dust Technologies, Inc.
2-2-1 Yaesu, Chuo-ku
Tokyo, 104-0028, Japan
(Address of Principal Executive
Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
☒ Form
20-F ☐ Form 40-F
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Issuance of Press Release
On August 22, 2024, the Company issued a press release announcing
its financial results for the fiscal year ended April 30, 2024.
The press release furnished in this report as Exhibit 99.1
shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under
the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Date: August 22, 2024 |
Pixie Dust Technologies, Inc. |
|
|
|
|
By: |
/s/ Yoichi Ochiai |
|
Name: |
Yoichi Ochiai |
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1
Pixie Dust Technologies, Inc. Announces
Fiscal Year 2024 Financial
Results
New York, NY and Tokyo, Japan, August 22, 2024 –
Pixie Dust Technologies, Inc. (Nasdaq: PXDT) (the “Company”), a Japanese technology company focused on commercializing
innovative products and materials utilizing proprietary wave technology, today announced its financial results for the fiscal year ended
April 30, 2024.
Fiscal Year Financial Results
The Company’s audited financial
statements for the fiscal year ended April 30, 2024 and the related notes, and related management’s discussion and analysis of
the Company’s financial condition and results of operations can be found in the Company’s Annual Report on Form 20-F filed
with the SEC, a copy of which can also be found on the Company’s website. The Company’s functional currency and reporting
currency is the Japanese yen (which we refer to as “JPY” or “¥”). The terms “dollar,” “USD,”
“US$” or “$” refer to U.S. dollars, the legal currency of the United States. Convenience conversions provided
in this press release of Japanese yen into U.S. dollars have been made at the exchange rate of ¥157.54 US$1.00, which was the foreign
exchange rate on April 30, 2024 as reported by the Board of Governors of the Federal Reserve System. All figures are expressed in Japanese
Yen and United States dollars unless otherwise stated.
| ● | Total
Revenue increased by 40.9% from ¥704,712 thousand in the fiscal year ended April
30, 2023 to ¥993,021 thousand ($6,303 thousand) in the fiscal year ended April 30, 2024,
primarily due to increases in product revenue of ¥340,205 thousand, partially offset
by a decrease in commissioned research and development of ¥23,433 thousand with the remaining
decrease being predominately due to decreases in solution service. |
| ● | Product
Sales were ¥523,154 thousand ($3,320 thousand) in the fiscal year ended April 30,
2024, representing a 186.0% increase from the prior year. This increase is primarily attributed
to the sales of the following products: kikippa (launched in April 2023), SonoRepro (launched
in November 2022) and iwasemi (launched in July 2022). |
| ● | Services Sales declined to ¥469,867 thousand ($2,983 thousand) in the fiscal year
ended April 30, 2024 from ¥521,763 thousand in the prior year. This decline in services is primarily due to our decision to reallocate
resources to product sales. |
| ● | Research and Development Expenses declined by 25.3%
from ¥686,557 thousand in fiscal year 2023 ended April 30, 2023 to ¥512,997 thousand ($3,256 thousand) in the fiscal year ended
April 30, 2024. This decline is primarily due to a shift in focus from the research and development of kikippa and VUEVO to product commercialization. |
| ● | Selling, General and Administrative Expenses increased
by 16.2% from ¥1,856,056 thousand for the fiscal year ended April 30, 2023 to ¥2,155,860 thousand ($13,684 thousand) for the
fiscal year ended April 30, 2024, mainly due to increases in marketing promotion expenses and personnel costs for sales and marketing
staff as we expand our marketing and sales efforts for our products, with the remaining increase related to rent expense and depreciation
expenses in connection with transferring to our new headquarters. |
| ● | Our other income, net increased by 47.4% from ¥43,798
thousand for the fiscal year ended April 30, 2023 to ¥64,567 thousand ($409 thousand) for the fiscal year ended April 30, 2024, primarily
due to an increase in foreign exchange remeasurement gains on cash held in U.S. dollars as a result of the receipt of the net proceeds
from the initial public offering of our ADSs, as well as a gain related to the change in fair value of warrants liability, partially
offset by a decrease in insurance proceeds. During the year ended April 30, 2023, we received insurance proceeds related to a claim for
losses that occurred in the year ended April 30, 2022. There were no such proceeds during the year ended April 30, 2024. |
| ● | Net
loss. We have incurred significant operating losses to date and negative cash flows since our inception. We incurred net loss of
¥1,965,491 thousand for the year ended April 30, 2023, and ¥1,974,536 thousand ($12,534 thousand) for the year ended April 30,
2024. As of April 30, 2024, we had an accumulated deficit of ¥6,356,788 thousand ($40,350 thousand). Our primary use of capital
resources has been to conduct research and development activities, expand our marketing and sales efforts for our products, organize
and staff our Company, develop our business plan, secure related intellectual property rights, and raise capital. |
| ● | Our principal sources of liquidity were cash and cash equivalents
totaling ¥2,135,513 thousand as of April 30, 2023 and ¥1,607,763 thousand ($10,205 thousand) as of April 30, 2024, which were
held and used for working capital purposes. Our cash and cash equivalents are comprised of cash on hand, demand deposits, and time deposits
maintained at various financial institutions. |
Forward-Looking Statements
Certain statements contained in this press
release, including those that express a belief, expectation or intention, as well as those that are not statements of historical
fact, are forward-looking statements. These forward-looking statements may include projections and estimates concerning our possible
or assumed future results of operations, financial condition, business strategies and plans, market opportunity, competitive
position, industry environment, and potential growth opportunities. In some cases, you can identify forward-looking statements by
terms such as “may”, “will”, “should”, “believe”, “expect”,
“could”, “intend”, “plan”, “anticipate”, “estimate”,
“continue”, “predict”, “project”, “potential”, “target,”
“goal” or other words that convey the uncertainty of future events or outcomes. You can also identify forward-looking
statements by discussions of strategy, plans or intentions. We have based these forward-looking statements on our current
expectations and assumptions about future events. While our management considers these expectations and assumptions to be
reasonable, because forward-looking statements relate to matters that have not yet occurred, they are inherently subject to
significant business, competitive, economic, regulatory and other risks, contingencies and uncertainties, most of which are
difficult to predict and many of which are beyond our control. These and other important factors, including, among others, those
discussed in our most recent annual report for the fiscal year ending April 30, 2024, filed under cover of Form 20-F with U.S.
Securities and Exchange Commission, under the headings “Risk Factors”, “Operating and Financial Review and
Prospects”, and “Business Overview” may cause our actual results, performance or achievements to differ materially
from any future results, performance or achievements expressed or implied by the forward-looking statements in this annual report.
Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking
statements in this press release include our expectations regarding our revenue, expenses, and other operating results.
About Pixie Dust Technologies, Inc.
Pixie Dust Technologies, Inc. is a Japanese
technology company focused on commercializing innovative products and materials utilizing proprietary wave technology. The Company is
currently focusing on two areas of product development: (1) “Personal Care & Diversity”, where wave control technology
is applied to mechanobiology and intervention/assistance in vision, hearing, and touch, and (2) “Workspace & Digital Transformation,”
where metamaterials (technology that creates properties through structure rather than material) and solutions to commercial design problems,
such as in offices or construction sites, are applied.
Pixie Dust Technologies Investor Relations Contact:
Email: PXDT_IR@pixiedusttech.com
Pixie Dust Technologies (NASDAQ:PXDT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pixie Dust Technologies (NASDAQ:PXDT)
Historical Stock Chart
From Nov 2023 to Nov 2024